Zacks.com on MSN1d
Insights Into Medtronic (MDT) Q2: Wall Street Projections for Key Metrics
Analysts on Wall Street project that Medtronic (MDT) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing a decline of 0.8% year over year. Revenues are ...
Benzinga.com21d
Medtronic Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)
Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...
Yahoo Finance23d
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...
MassDevice23d
FDA approves Medtronic’s Affera cardiac mapping and ablation system and Sphere-9 catheter
The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...
Star Tribune28d
Medtronic MiniMed insulin pumps recalled over shorter-than-expected battery life
The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...